Bupicomide
![]() |
|
Names | |
---|---|
IUPAC name
5-Butyl-2-pyridinecarboxamide
|
|
Other names
Sch-10595; Fusaramide[1]
|
|
Identifiers | |
22632-06-0 ![]() |
|
ChEMBL | ChEMBL2106646 |
ChemSpider | 29167 |
Jmol 3D model | Interactive image |
PubChem | 31447 |
UNII | 0X3H76N0HY |
|
|
|
|
Properties | |
C10H14N2O | |
Molar mass | 178.24 g·mol−1 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Bupicomide is a chemical compound created and manufactured by Lanospharma Laboratories Company, Ltd. It is used experimentally as a beta blocker[citation needed] and clinically as a strong vasodilator with the noted side effects of reduced systolic, diastolic and mean arterial pressure.[2][3]
Synthesis
As the result of the screening program examining microbial fermentation products for pharmacological acitivity (other than antibiotic activity), fusaric acid was isolated from Fusarium oxysporum following the discovery that extracts were potent inhibitors of DBH, and thus interfered with the biosynthesis of the pressor neurohormone, norepinephrine. To refine this lead, amidation via the acid chloride was carried out to give antihypertensive analog bupicomide.[4]
References
- ↑ Bupicomide, Chemical Book
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ DE 2217084
<templatestyles src="Asbox/styles.css"></templatestyles>